BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6374193)

  • 1. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
    Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
    Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
    Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
    Sasaki I; Morihana T; Kaneko A; Michi K; Takahashi K; Fukuoka F; Satoh T; Yoshinari N; Ohne M; Hara H
    Jpn J Antibiot; 1990 Dec; 43(12):2035-68. PubMed ID: 2086820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental and clinical studies of cefaclor in oral surgery].
    Morihana K; Sakamoto H; Gotoh J; Konnai T; Uematsu M; Toyoura T; Sasaki J; Ohno K; Yoshida H; Hasegawa M
    Jpn J Antibiot; 1984 Jun; 37(6):1006-22. PubMed ID: 6387212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
    Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
    Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
    Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y
    Jpn J Antibiot; 1987 Jan; 40(1):1-24. PubMed ID: 3295321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
    Oizumi K; Watanabe A; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Ohmichi M; Tamura M; Konishi K; Gomi K
    Jpn J Antibiot; 1990 Nov; 43(11):1914-47. PubMed ID: 2287058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
    Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
    Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative double-blind study of cefroxadine and cephalexin in the treatment of complicated urinary tract infection].
    Kamidono S; Harada M; Ishigami J; Takasaki N; Miyazaki S; Furusawa T; Mizunoe Y; Ito K; Momose S; Nakamuta S
    Jpn J Antibiot; 1983 Sep; 36(9):2571-94. PubMed ID: 6361324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B; Lambert-Zechovsky N; Cathlin C
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical results of cefaclor treatment of infections of oral regions].
    Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
    Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field].
    Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Ito T; Tanabe M; Fukuhara A; Sakakibara O
    Jpn J Antibiot; 1985 Mar; 38(3):859-68. PubMed ID: 3897613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies of cefaclor for respiratory tract infections].
    Hiraga Y; Kikuchi K; Yamamoto A
    Jpn J Antibiot; 1984 Apr; 37(4):581-8. PubMed ID: 6471379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.